These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis. Lancet; 1973 Feb; 1(7798):275-80. PubMed ID: 4119168 [No Abstract] [Full Text] [Related]
46. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis. Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830 [TBL] [Abstract][Full Text] [Related]
47. Treatment of rheumatoid arthritis with D-penicillamine. Cooley DA; Weaver AL Nebr Med J; 1978 Dec; 63(12):402-4. PubMed ID: 723995 [No Abstract] [Full Text] [Related]
48. D-penicillamine in the treatment of rheumatoid arthritis. McKenna CH Minn Med; 1979 Dec; 62(12):875. PubMed ID: 522849 [No Abstract] [Full Text] [Related]
49. A continuing look at penicillamine. Baum J J Rheumatol; 1979; 6(1):3-6. PubMed ID: 439108 [No Abstract] [Full Text] [Related]
50. [Chlorbutin, azathioprine, D-penicillamine, and levamisole (Decaris) in the treatment of rheumatoid arthritis patients. I. Comparative analysis of side effects]. Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV Ter Arkh; 1981; 53(7):86-96. PubMed ID: 6457409 [No Abstract] [Full Text] [Related]
52. [The long term treatment of rheumatoid arthritis with D-penicillamine]. Krüger HH Verh Dtsch Ges Rheumatol; 1969; 1():387-94. PubMed ID: 4997350 [No Abstract] [Full Text] [Related]
53. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis]. Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436 [No Abstract] [Full Text] [Related]
54. The use of penicillamine in the treatment of rheumatoid arthritis and scleroderma. Baum J Scand J Rheumatol Suppl; 1979; (28):65-70. PubMed ID: 377472 [TBL] [Abstract][Full Text] [Related]
55. Clinical response in relation to dose of penicillamine in the treatment of rheumatoid arthritis. Lyle WH Int J Clin Pharmacol Res; 1984; 4(6):403-8. PubMed ID: 6533084 [TBL] [Abstract][Full Text] [Related]
56. [Pyrithioxin in the treatment of patients with rheumatoid arthritis (comparative study with D-penicillamine)]. Tosković B Reumatizam; 1983; 30(3):60-8. PubMed ID: 6351211 [No Abstract] [Full Text] [Related]
57. Studies on the metabolism of D-penicillamine and its interaction with probenecid in cystinuria and rheumatoid arthritis. Yu TF; Roboz J; Johnson S; Kaung C J Rheumatol; 1984 Aug; 11(4):467-70. PubMed ID: 6481720 [TBL] [Abstract][Full Text] [Related]
58. [A case of rheumatoid arthritis associated with leukocytopenia during D-penicillamine treatment]. Negishi M; Sato H; Sekine F; Mita S; Ono I; Kobayashi K; Oseto Y; Hamai T; Takahashi T Arerugi; 1982 Jun; 31(6):350-4. PubMed ID: 7181659 [No Abstract] [Full Text] [Related]
59. Reaction to D-penicillamine in rheumatoid arthritis. Day AT; Golding JR Br Med J; 1973 Sep; 3(5880):593. PubMed ID: 4726943 [No Abstract] [Full Text] [Related]
60. Thrombotic thrombocytopenic purpura associated with D-penicillamine treatment in rheumatoid arthritis. Speth PA; Boerbooms AM; Holdrinet RS; Van de Putte LB; Meyer JW J Rheumatol; 1982; 9(5):812-3. PubMed ID: 6890995 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]